KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Gross Profit: 2009-2024

Historic Gross Profit for Arbutus Biopharma (ABUS) over the last 16 years, with Dec 2024 value amounting to $6.2 million.

  • Arbutus Biopharma's Gross Profit fell 60.49% to $529,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year increase of 116.64%. This contributed to the annual value of $6.2 million for FY2024, which is 65.98% down from last year.
  • Arbutus Biopharma's Gross Profit amounted to $6.2 million in FY2024, which was down 65.98% from $18.1 million recorded in FY2023.
  • In the past 5 years, Arbutus Biopharma's Gross Profit ranged from a high of $39.0 million in FY2022 and a low of $6.2 million during FY2024.
  • Its 3-year average for Gross Profit is $21.1 million, with a median of $18.1 million in 2023.
  • In the last 5 years, Arbutus Biopharma's Gross Profit skyrocketed by 255.11% in 2022 and then crashed by 65.98% in 2024.
  • Over the past 5 years, Arbutus Biopharma's Gross Profit (Yearly) stood at $6.9 million in 2020, then spiked by 58.92% to $11.0 million in 2021, then soared by 255.11% to $39.0 million in 2022, then crashed by 53.51% to $18.1 million in 2023, then tumbled by 65.98% to $6.2 million in 2024.